Simulation-Based Gastrointestinal Endoscopy Sedations: A Novel Validation to Multidrug Pharmacodynamic Modeling.

Area of Science:

• Pharmacodynamics
• Anesthesiology
• Clinical Pharmacology

Background:

• Pharmacodynamic models of anesthetic interactions exist but face challenges in clinical application due to differing conditions and single-endpoint limitations.
• Validating these models against real-world clinical outcomes is crucial for their practical utility.

Purpose of the Study:

• To propose and validate a novel method for assessing pharmacodynamic model performance in predicting recovery and intraprocedural sedation adequacy.
• To evaluate a three-drug (midazolam, opioid, propofol) pharmacodynamic model using data from published clinical studies.

Main Methods:

• Extracted mean drug dose, sedation level, procedure type, and recovery time from six published clinical studies.
• Simulated drug regimens based on extracted data using a published deep sedation model.
• Compared model-predicted recovery times and sedation scores with original clinical study outcomes.

Main Results:

• The three-drug pharmacodynamic model accurately predicted recovery times in 8 out of 9 simulated regimens.
• Lower midazolam doses were associated with faster patient recovery.
• Model predictions for intraprocedural sedation levels were consistent with clinical outcomes in 5 out of 7 regimens.

Conclusions:

• The validated three-drug pharmacodynamic model effectively describes sedation courses during gastrointestinal endoscopy.
• Model predictions align well with clinical study results, demonstrating its utility.
• This approach enables repeated, large-scale validation of pharmacodynamic models for clinical application.